LCS
MRK icon

Levin Capital Strategies’s Merck MRK Stock Holding History

Levin Capital Strategies’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.63M Sell
12,656
-666
-5% -$78K 0.11% 113
2026
Q1 		$1.6M Buy
+13,322
New +$1.54M 0.12% 106
2022
Q3 		– Sell
-4,485
Closed -$409K – 268
2022
Q2 		$409K Hold
4,485
– – 0.05% 150
2022
Q1 		$368K Sell
4,485
-2,000
-31% -$158K 0.04% 193
2021
Q4 		$497K Buy
6,485
+2,060
+47% +$164K 0.05% 163
2021
Q3 		$332K Sell
4,425
-442
-9% -$33.6K 0.03% 220
2021
Q2 		$379K Sell
4,867
-97,498
-95% -$7.25M 0.04% 196
2021
Q1 		$7.53M Sell
102,365
-8,246
-7% -$608K 0.8% 31
2020
Q4 		$8.63M Buy
110,611
+105,265
+1,969% +$8.05M 0.97% 29
2020
Q3 		$423K Buy
+5,346
New +$419K 0.06% 152
2019
Q1 		– Sell
-4,413
Closed -$322K – 227
2018
Q4 		$322K Sell
4,413
-2,279,789
-100% -$161M 0.01% 190
2018
Q3 		$155M Sell
2,284,202
-161,070
-7% -$10.3M 2.66% 13
2018
Q2 		$142M Buy
2,445,272
+158,327
+7% +$8.93M 2.44% 15
2018
Q1 		$119M Buy
2,286,945
+1,332,826
+140% +$72M 2.16% 19
2017
Q4 		$51.2M Buy
954,119
+251,392
+36% +$13.9M 0.87% 35
2017
Q3 		$42.9M Buy
+702,727
New +$42.6M 0.73% 35
2016
Q2 		– Sell
-964,467
Closed -$48.7M – 354
2016
Q1 		$48.7M Buy
+964,467
New +$47.2M 0.88% 28
2015
Q1 		– Sell
-50,504
Closed -$2.74M – 411
2014
Q4 		$2.74M Sell
50,504
-224,885
-82% -$12.5M 0.04% 152
2014
Q3 		$15.6M Sell
275,389
-2,244,517
-89% -$126M 0.24% 77
2014
Q2 		$139M Sell
2,519,906
-1,691,812
-40% -$92.3M 2.14% 10
2014
Q1 		$228M Sell
4,211,718
-1,003,041
-19% -$51.9M 3.82% 4
2013
Q4 		$249M Buy
5,214,759
+1,646,818
+46% +$75.3M 4.01% 5
2013
Q3 		$162M Buy
3,567,941
+588,386
+20% +$26.9M 2.76% 8
2013
Q2 		$132M Buy
+2,979,555
New +$133M 2.38% 11

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Levin Capital Strategies's MRK Position: Q2 2026 in Review

Levin Capital Strategies reduced its Merck (MRK) stake by 5% in Q2 2026, selling an estimated $78K and leaving 12,656 shares worth $1.63M. The position accounts for 0.11% of the portfolio, ranked #113.

Levin Capital Strategies first reported a position in MRK in Q2 2013 and has held it in 24 quarters since. The position peaked at $249M in Q4 2013. 3,842 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Levin Capital Strategies held 12,656 shares of Merck worth $1.63M as of Q2 2026.
  • Levin Capital Strategies sold 666 Merck shares in Q2 2026, an estimated $78K.
  • Merck made up 0.11% of Levin Capital Strategies's portfolio in Q2 2026, its #113 holding.
  • Levin Capital Strategies first reported a position in Merck in Q2 2013 and has held it in 24 quarters since.
  • Levin Capital Strategies's Merck position peaked at $249M in Q4 2013.
  • 3,842 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Levin Capital Strategies's 13F filing for Q2 2026, filed 31 Jul 2026.